MindMaze Therapeutics Holding SA (FRA:V6M)

Market Cap	25.93M
Revenue (ttm)	689.57K
Net Income	-10.64M
EPS	-0.52
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1640
Previous Close	0.1680
Day's Range	0.1640 - 0.1640
52-Week Range	0.1630 - 2.9350
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About FRA:V6M

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics’ ne...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2012
• Country: Switzerland
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: V6M

Financial Performance

Financial numbers in CHF

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error